Canonical Question
Liver – Functions
Master answer
Pharmacodynamics
- Altered receptor binding
- Postulated for relative resistance to non-depolarizing NMB in liver failure
Pharmacokinetics
- Absorption
- Portal hypertension and interstitial oedema reduce absorption of drugs
- Hepatic dysfunction
- Increased bioavailability of drugs susceptible to hepatic first pass metabolism (diazepam)
- Decreased activation of pro-drug (clopidogrel requires CYP2C19 activation)
- Distribution
- Decreased synthesis of plasma proteins
- Increases free fraction of protein bound drugs
→ Unbound drug more permeable → increased volume of distribution (amiodarone)
→ Unbound drug more active
- Increases free fraction of protein bound drugs
- Hypervolaemia secondary to renal Na+ and H2O retention
- Increased Vd for drugs distributed to extracellular volume
- Decreased pH alteres ionization of acids and bases (acids ionized when pH above pKa and bases ionized when pH below pKa)
- Decreased synthesis of plasma proteins
- Metabolism
- Decreased hepatic metabolism
- Increases T1/2b of hepatically metabolized drug → Accumulation of drug if no alteration
- Decreased butylcholinesterase production → Decreased metabolism for drugs metabolised by plasma esterases (suxamethonium – however clinically not significant for this drug) – red cell esterases remain therefore no effect for remifentanyl
- Decreased hepatic metabolism
- Elimination
- Hepatorenal syndrome → decreased renal clearance
- However renal drug clearance tends to decrease even in absence of renal impariment (drugs not hepatically converted to more water soluble metabolites)
- Biliary clearance of drug is reduced
Sakurai 2016
Exam appearances
| Exam | Exact wording | Relationship | Success |
|---|---|---|---|
| 2012B Q05 | How does liver failure affect the pharmacology of drugs? | historical_member | — |